Crypto News

Swift’s blockchain-based ledger ready for initial use

Crypto VC Paradigm just closed $1.2B fourth fund to chase AI and robotics

Coinbase Wins UK License to Offer Stocks, Expanding Beyond Crypto, as Ondo’s New Perpetual Markets Bridge Traditional Assets and DeFi

QuickSwap upgrades perpetuals platform, ending V1 Perps by July 14, 2026

CYPR Token Crashes 88% After Nium Acquires Cypher Wallet: No Compensation for Holders

Altseason 2026 Could Rewrite Crypto History—Here Are 5 Meme Coins Worth Watching Right Now

Curve DAO Token (CRV) Price Outlook 2026-2030: Can It Break Its Multi-Year Trading Range?

Is HYPE Better Than XRP? We Compared Price, ETFs, and Growth Potential

Bonfire topped with mosque replica and anti-Islam banners

The Centralization Paradox: How Structural Forces Pull Crypto Back to Gatekeepers

BNB Chain’s H2 2026 Roadmap Targets AI Agents as BNB Crypto Price Lags Behind

Swift Readies Ledger for 24/7 Token Transfers—Though True Settlement Is Stuck on Old Rails

Bomb Crypto (POL) (BCOIN) Price Today | Live Chart

Georgia Launched a Stablecoin, But Sierra Leone Is Going Further

Base Wallet Holders Can Spend at Visa-Accepting Merchants Through Oobit’s DePay

Replica of mosque placed on top of loyalist bonfire

Moygashel: Replica of mosque placed on top of loyalist bonfire

NIGHT Price Stays Under Pressure Despite Midnight’s Token Terminal Partnership

Ionis Pharmaceuticals, Inc announced that its Phase III cardiovascular outcome clinical trial "Cardio-Ttransform" for the drug Eplontersen failed to meet its primary endpoint in the analysis at week 140.